Key Takeaways

  • Opioid use disorder (OUD) affects over 6 million Americans and is the leading driver of overdose deaths in the United States.
  • Medication-assisted treatment (MAT) with buprenorphine or methadone reduces overdose death risk by up to 50% and is considered the gold standard of care.
  • Medical detox is strongly recommended before entering rehab — opioid withdrawal, while rarely fatal, is intensely uncomfortable and relapse risk is extremely high without supervision.
  • Most private insurance, Medicaid, and Medicare cover opioid addiction treatment under federal mental health parity laws.
  • Long-term recovery requires more than detox — behavioral therapy, peer support, and ongoing MAT produce the best outcomes.

What Is Opioid Use Disorder?

Opioid use disorder (OUD) is a chronic brain disease characterized by compulsive use of opioids — including prescription painkillers like oxycodone, hydrocodone, and morphine, as well as illicit opioids like heroin and illicitly manufactured fentanyl — despite serious negative consequences. The National Institute on Drug Abuse (NIDA) classifies addiction as a brain disorder because repeated opioid exposure fundamentally changes the structure and function of the brain's reward, motivation, and decision-making systems.

Opioids work by binding to mu-opioid receptors throughout the brain and body, blocking pain signals and triggering a massive release of dopamine — the neurotransmitter responsible for pleasure and reinforcement. Over time, the brain reduces its natural dopamine production and becomes dependent on opioids to feel normal. This is why people with OUD experience intense cravings, withdrawal symptoms when they stop, and difficulty controlling their use — these are neurological responses, not moral failures.

According to the Substance Abuse and Mental Health Services Administration (SAMHSA), approximately 6.1 million Americans aged 12 or older had opioid use disorder in 2023. Despite this, fewer than 25% received treatment in the past year — a treatment gap that continues to cost tens of thousands of lives annually.

80,000+
Opioid-involved overdose deaths in 2023 (CDC)
6.1M
Americans with opioid use disorder (SAMHSA 2023)
~50%
Reduction in overdose death risk with MAT

Signs & Symptoms of Opioid Addiction

Opioid use disorder develops on a spectrum. Many people begin with legitimate prescription use and gradually develop physical dependence and, in some cases, addiction. Recognizing the signs early — in yourself or a loved one — dramatically improves outcomes. The American Society of Addiction Medicine (ASAM) outlines the following diagnostic criteria for opioid use disorder, which mirrors the DSM-5 criteria:

Behavioral Signs

  • Taking opioids in larger amounts or for longer than intended
  • Persistent desire or unsuccessful efforts to cut down or control use
  • "Doctor shopping" — visiting multiple providers to obtain prescriptions
  • Spending significant time obtaining, using, or recovering from opioids
  • Giving up important activities (work, family, social events) due to opioid use
  • Continuing to use despite knowing it is causing physical or psychological problems
  • Using in physically hazardous situations (driving, operating machinery)

Physical Signs

  • Pinpoint (very small) pupils, especially when sedated
  • Drowsiness, "nodding off," slurred speech
  • Unexplained weight loss
  • Track marks or bruising from injection use
  • Tolerance — needing more of the drug to achieve the same effect
  • Withdrawal symptoms when stopping or reducing use
  • Neglect of personal hygiene and appearance

Dependence vs. Addiction: An Important Distinction

Physical dependence — experiencing withdrawal when stopping — can occur in anyone who takes opioids regularly, including patients prescribed them for pain management. Addiction (opioid use disorder) involves a compulsive pattern of use and loss of control. Both conditions are medically treatable, but they require different approaches. If you're unsure which applies to you or a loved one, a brief phone assessment with one of our specialists can help clarify next steps.

Overdose Risk & Fentanyl Contamination

The opioid overdose crisis has reached unprecedented levels, driven almost entirely by illicitly manufactured fentanyl (IMF) — a synthetic opioid estimated to be 50–100 times more potent than morphine. According to the Centers for Disease Control and Prevention (CDC), fentanyl and other synthetic opioids accounted for approximately 75% of all drug overdose deaths in 2023.

What makes the current landscape particularly dangerous is that fentanyl is now found in virtually all illicit drug supplies — not just heroin. Pills sold as oxycodone, Xanax, Adderall, and even cocaine and methamphetamine have been found to contain lethal doses of fentanyl. Because fentanyl is so concentrated, a quantity invisible to the naked eye can cause respiratory failure within minutes.

Opioid Overdose: Recognize the Signs & Act Immediately

Signs of opioid overdose include unresponsiveness, slow or stopped breathing, blue lips or fingertips (cyanosis), gurgling or choking sounds, and pinpoint pupils. If you suspect an overdose:

  • Call 911 immediately
  • Administer naloxone (Narcan) if available — it can reverse an opioid overdose within minutes
  • Perform rescue breathing if the person is not breathing
  • Stay with the person until emergency services arrive

Naloxone is available without a prescription at most pharmacies in all 50 states.

Opioid Withdrawal: What to Expect

Opioid withdrawal is the body's response to the sudden absence of a substance it has become physically dependent on. While rarely life-threatening for most people (unlike alcohol withdrawal), opioid withdrawal is intensely uncomfortable — and the severe discomfort is one of the primary reasons people relapse during unsupervised attempts to quit.

The timeline and severity of withdrawal depends on the specific opioid used, duration of use, and individual physiology. Short-acting opioids like heroin and oxycodone cause withdrawal symptoms to appear within 8–24 hours; long-acting opioids like methadone may not produce symptoms for 36–48 hours.

Common Opioid Withdrawal Symptoms

  • Early (8–24 hours): Anxiety, agitation, muscle aches, runny nose, sweating, yawning, insomnia
  • Peak (36–72 hours): Severe nausea, vomiting, diarrhea, abdominal cramping, goosebumps, rapid heart rate, elevated blood pressure
  • Late (1–2 weeks): Persistent insomnia, fatigue, dysphoria, cravings — this phase can last weeks to months (post-acute withdrawal syndrome, or PAWS)

Why Medically Supervised Detox Matters

Attempting to detox from opioids at home — "going cold turkey" — carries serious risks. Beyond the misery of withdrawal, dehydration from vomiting and diarrhea can become dangerous, and the risk of relapse is extremely high. Relapse after a period of abstinence is particularly dangerous because tolerance drops rapidly — a dose that felt normal before can now cause a fatal overdose. Medical detox provides 24/7 monitoring, IV fluids, and medications to safely manage every symptom.

Medical Detox for Opioids

Medical detoxification is the first stage of opioid addiction treatment, designed to safely manage withdrawal while stabilizing the patient medically. Medical detox for opioids is typically conducted in a hospital or residential detox facility where nursing staff and physicians provide around-the-clock monitoring and medication management.

The standard of care for opioid detox involves medication to minimize withdrawal discomfort and cravings. The most commonly used protocols include:

  • Buprenorphine (Suboxone, Subutex): A partial opioid agonist that significantly reduces withdrawal symptoms and cravings. Often initiated during detox and continued as ongoing MAT.
  • Methadone: A long-acting full opioid agonist that eliminates withdrawal and cravings. Used in licensed opioid treatment programs (OTPs).
  • Clonidine: A non-opioid medication that reduces autonomic symptoms like sweating, anxiety, and elevated blood pressure during withdrawal.
  • Loperamide, ondansetron, and other supportive medications to manage diarrhea, nausea, and muscle cramping.

Medical detox alone is not treatment — it is the first step. The NIAAA and SAMHSA both emphasize that detox must be followed by ongoing treatment — either inpatient rehabilitation, PHP, IOP, or outpatient MAT — to address the underlying behavioral and psychological aspects of addiction.

Ready to Start Treatment? We Can Help Right Now.

Free, confidential assessment. Most insurance accepted. Same-day admissions available.

(844) 561-0606

Medication-Assisted Treatment (MAT)

Medication-assisted treatment (MAT) is the use of FDA-approved medications — combined with counseling and behavioral therapies — to treat opioid use disorder. MAT is the most thoroughly evidence-based treatment for OUD and is endorsed by SAMHSA, NIDA, ASAM, and every major medical authority in the United States.

Research consistently demonstrates that patients maintained on buprenorphine or methadone have dramatically better outcomes than those who receive abstinence-only treatment: lower rates of illicit opioid use, fewer overdoses, reduced criminal activity, better employment outcomes, and significantly lower mortality. Learn more about our network's MAT programs.

Medication How It Works Setting Best For
Buprenorphine (Suboxone, Sublocade) Partial opioid agonist — reduces cravings and withdrawal without producing a significant high Office-based prescribing (any DEA-licensed provider) Most patients with OUD; flexible outpatient setting
Methadone Full opioid agonist — eliminates withdrawal and cravings completely at therapeutic doses Licensed Opioid Treatment Programs (OTPs) only Severe OUD; patients who have not responded to buprenorphine
Naltrexone (Vivitrol) Opioid antagonist — blocks opioid receptors entirely; no effect if opioids are taken Office-based; monthly injection available Motivated patients who have completed detox; works best with strong support system

A common misconception is that MAT simply substitutes one addiction for another. This is medically inaccurate. When taken as prescribed, buprenorphine and methadone stabilize brain chemistry, allowing patients to function normally — similar to how insulin manages diabetes. The goal is not perpetual dependence, but stabilization, rehabilitation, and eventual tapering when clinically appropriate.

Levels of Care: Finding the Right Fit

Opioid addiction treatment is not one-size-fits-all. The appropriate level of care depends on the severity of the addiction, co-occurring medical or psychiatric conditions, prior treatment history, and social support systems. The ASAM Patient Placement Criteria provide a standardized framework for matching patients to the right level of care.

Inpatient / Residential Rehab

Inpatient rehab provides 24/7 clinical care in a residential setting, typically lasting 28–90 days. It is the most appropriate level of care for patients with severe OUD, unstable housing, co-occurring psychiatric conditions, or a history of multiple failed outpatient attempts. Residential programs combine medical stabilization, individual and group therapy, MAT, life skills training, and discharge planning. Research published in the Journal of Substance Abuse Treatment shows that longer residential stays are associated with significantly better long-term outcomes.

Partial Hospitalization Program (PHP)

PHP provides intensive, structured treatment — typically 5–6 hours per day, 5 days per week — while allowing patients to return home or to sober living in the evenings. PHP is an appropriate step-down from inpatient care or a step-up for patients who need more structure than standard outpatient therapy. PHP programs for opioid addiction incorporate MAT management, individual therapy, group therapy, psychiatric services, and family counseling.

Intensive Outpatient Program (IOP)

IOP is a flexible, less intensive option that typically involves 3 hours of programming per day, 3–5 days per week. IOP allows patients to maintain work, school, and family responsibilities while receiving structured addiction treatment. It is best suited for patients with stable housing and a strong support system who have already completed detox and are stable on MAT. Dual diagnosis IOP programs address co-occurring mental health conditions alongside addiction.

Behavioral Therapies That Work

Medication alone is not sufficient for lasting recovery from opioid addiction. Behavioral therapies address the psychological, emotional, and social dimensions of OUD — teaching coping skills, identifying triggers, repairing relationships, and building a foundation for long-term sobriety. The most evidence-based behavioral therapies for opioid addiction include:

  • Cognitive Behavioral Therapy (CBT): Identifies and challenges distorted thinking patterns that contribute to drug use. Teaches practical coping skills for managing cravings, stress, and high-risk situations. Considered first-line behavioral treatment by NIDA.
  • Contingency Management (CM): Uses positive reinforcement — vouchers, prizes, or privileges — to reward drug-free urine screens and treatment attendance. Among the most effective behavioral interventions in randomized controlled trials.
  • Motivational Interviewing (MI): A collaborative, person-centered counseling style that helps patients resolve ambivalence about treatment and strengthen their own motivation for change.
  • Dialectical Behavior Therapy (DBT): Especially effective for patients with co-occurring borderline personality disorder, trauma histories, or chronic suicidality alongside OUD.
  • 12-Step Facilitation / SMART Recovery: Peer support models that provide community, accountability, and a structured framework for maintaining sobriety after formal treatment ends.

Co-Occurring Mental Health Conditions

More than 50% of people with opioid use disorder also have a co-occurring psychiatric condition — most commonly depression, anxiety, PTSD, or bipolar disorder. Treating addiction without addressing the underlying mental health condition dramatically reduces the chances of sustained recovery. Our network includes specialized dual diagnosis programs that treat both conditions simultaneously using integrated treatment teams.

Does Insurance Cover Opioid Addiction Treatment?

Yes — in most cases, health insurance covers opioid addiction treatment. The Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 requires that insurance plans covering mental health and substance use disorder benefits must do so at the same level as medical and surgical benefits. The Affordable Care Act (ACA) further expanded coverage by classifying substance use treatment as an essential health benefit.

Medicaid, which covers more than 40% of adults with opioid use disorder, covers opioid treatment in all 50 states — including MAT with buprenorphine and methadone, inpatient detox, residential treatment, and outpatient services. Medicare Part B covers methadone for OUD treatment when provided through a licensed OTP, and covers buprenorphine when prescribed by a qualified provider.

Private insurance coverage varies by plan. Most plans cover medical detox, inpatient rehabilitation, PHP, IOP, and outpatient MAT — but authorization requirements, in-network restrictions, and coverage limits can make navigating benefits challenging. Our specialists verify your insurance benefits before connecting you to any treatment center — at no cost to you — so you know exactly what is covered before you arrive.

How to Get Help Today

If you or someone you love is struggling with opioid addiction, help is available right now. Addiction Helpline America connects individuals and families with accredited treatment centers nationwide — matched to your specific insurance, location, and clinical needs. Our service is completely free, confidential, and available 24 hours a day, 7 days a week.

When you call, a compassionate treatment specialist will:

  • Listen to your situation without judgment
  • Help you understand your treatment options
  • Verify your insurance benefits at no cost
  • Connect you with an accredited treatment center that meets your needs
  • Assist with logistics to help you get admitted as quickly as possible — often the same day

You do not need to be ready to commit to treatment to call. Many people call to ask questions, explore options, or get guidance on helping a loved one. There is no obligation, no cost, and no pressure. Every call is private and HIPAA-compliant.

Call Now — Free, Confidential, No Obligation

Specialists available 24/7. Most insurance accepted. Same-day admissions in most states.

(844) 561-0606

Frequently Asked Questions

There is no fixed timeline. NIDA recommends a minimum of 90 days of treatment for most people with opioid use disorder to achieve meaningful outcomes. Many patients remain on buprenorphine or methadone for years — or indefinitely — and this is considered appropriate medical management, not a treatment failure. The severity of the addiction, presence of co-occurring disorders, and social support all influence how long treatment is needed.
Yes. Many treatment programs accept patients without insurance through sliding-scale fees, state-funded programs, or SAMHSA block grants. In many states, Medicaid covers opioid treatment for low-income individuals with minimal or no out-of-pocket cost. Call our helpline and we will work to identify options for your specific situation regardless of your insurance status.
No — this is a common misconception. Buprenorphine is a partial opioid agonist that, when taken as prescribed at stable therapeutic doses, does not produce intoxication or euphoria. It stabilizes brain chemistry and eliminates withdrawal and cravings, allowing patients to function normally. Major medical organizations — including ASAM, SAMHSA, and NIDA — recommend buprenorphine as a first-line treatment for OUD. Withholding effective medication based on this misconception has cost countless lives.
Relapse is a common part of the recovery process for many people with opioid use disorder — it does not mean treatment has failed. If a relapse occurs, the most important thing is to seek help immediately. Tolerance drops quickly after abstinence, meaning the same dose used before treatment can now cause a fatal overdose. Contact our helpline and we will help you get back into treatment as quickly as possible. Many people enter treatment multiple times before achieving sustained recovery.
Helping a loved one who is unwilling to seek treatment is one of the most difficult situations families face. We recommend calling our helpline to speak with a specialist who can guide you through evidence-based intervention approaches, including CRAFT (Community Reinforcement and Family Training), which research shows is more effective than traditional confrontational interventions. We can also connect families with Al-Anon, Nar-Anon, and other peer support resources.
Physical dependence means the body has adapted to the presence of opioids and will experience withdrawal if they are stopped. This can happen to anyone who takes opioids regularly — including patients with chronic pain who take them as prescribed. Opioid use disorder (addiction) involves a compulsive pattern of use, loss of control, and continued use despite negative consequences. Dependence can exist without addiction. Both are medical conditions that benefit from professional evaluation and support.

Sources

  1. National Institute on Drug Abuse. (2024). Drug Misuse and Addiction. nida.nih.gov
  2. SAMHSA. (2023). National Survey on Drug Use and Health (NSDUH). samhsa.gov
  3. Centers for Disease Control and Prevention. (2024). Drug Overdose Deaths. cdc.gov
  4. American Society of Addiction Medicine. (2023). National Practice Guideline for the Treatment of Opioid Use Disorder. asam.org
  5. SAMHSA. (2023). Medications for Opioid Use Disorder: Treatment Improvement Protocol 63. samhsa.gov
  6. National Institute on Drug Abuse. (2023). Principles of Effective Treatment. nida.nih.gov
  7. Mattick RP, et al. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews.

Dr. James Whitfield, MD

Board-Certified Addiction Medicine Specialist

Dr. Whitfield is a board-certified addiction medicine physician with over 15 years of experience treating opioid use disorder, alcohol dependence, and co-occurring psychiatric conditions. He completed his fellowship in addiction medicine at Johns Hopkins University School of Medicine and currently serves as a clinical advisor for addiction treatment facilities across the southeastern United States.

Related Articles